126334-26-7

Basic information

• Product Name: 4'-Bromononanophenone, 98%
• Synonyms: 4'-Bromononanophenone, 98%;1-Nonanone,1-(4-bromophenyl)-;1-(4-Bromo-phenyl)-nonan-1-one
• CAS NO: 126334-26-7
• Molecular Formula: C₁₅H₂₁BrO
• Molecular Weight: 297.23
• EINECS: -0
• Mol File: 126334-26-7.mol
• Article Data: 4

Chemical Properties

• Melting Point: 67-69°C
• Boiling Point: 138-140°C/0.1mm
• Flash Point: 138-140°C/0.1mm
• Appearance: /
• Density: 1.176g/cm³
• CAS DataBase Reference: 4'-Bromononanophenone, 98%(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-Bromononanophenone, 98%(126334-26-7)
• EPA Substance Registry System: 4'-Bromononanophenone, 98%(126334-26-7)

Safety Data

• Hazardous Substances Data: 126334-26-7(Hazardous Substances Data)

Usage

General Description

4'-Bromononanophenone, 98% is a chemical compound with a purity of 98%. It is a derivative of phenylacetone, a substance known for its role in the synthesis of amphetamine-type stimulants. 4'-Bromononanophenone has a bromine atom attached to the fourth carbon of a nine-carbon chain, and a phenyl group attached to the other end. This chemical is used in the manufacture of pharmaceuticals, as well as in the production of other organic compounds. Due to its high purity level, it is suitable for use in research and industrial processes requiring precise and consistent chemical properties.

Upstream product

• 108-86-1 bromobenzene 
• 764-85-2 Nonanoyl chloride 
• 76287-56-4 1-(4-bromophenyl)-1-hydroxynonane 
• 111-66-0 oct-1-ene 
• 918350-11-5 4-bromo-2-(methylsulfanyl)benzaldehyde 
• 629-27-6 1-Iodooctane 
• 201230-82-2 carbon monoxide 
• 183677-71-6 2-(4-bromophenyl)-5,5-dimethyl-1,3,2-dioxaborinane 

Downstream Products

• 51554-94-0 4-bromo-1-(1-nonyl)benzene 
• 92724-74-8 α-<4-Brom-phenyl>nonylamin 

Relevant articles and documents

Cu/Mn bimetallic catalysis enables carbonylative Suzuki-Miyaura coupling with unactivated alkyl electrophiles

A bimetallic system consisting of Cu-carbene and Mn-carbonyl co-catalysts was employed for carbonylative C-C coupling of arylboronic esters with alkyl halides, allowing for the convergent synthesis of ketones. The system operates under mild conditions and exhibits complementary reactivity to Pd catalysis. The method is compatible with a wide range of arylboronic ester nucleophiles and proceeds smoothly for both primary and secondary alkyl iodide electrophiles. Preliminary mechanistic experiments corroborate a hypothetical catalytic mechanism consisting of co-dependent cycles wherein the Cu-carbene co-catalyst engages in transmetallation to generate an organocopper nucleophile, while the Mn-carbonyl co-catalyst activates the alkyl halide electrophile by single-electron transfer and then undergoes reversible carbonylation to generate an acylmanganese electrophile. The two cycles then intersect with a heterobimetallic, product-releasing C-C coupling step.

ALYKYLENE DERIVATIVE HAVING EDG RECEPTOR ANTAGONISM

PROBLEM TO BE SOLVED: To provide novel compounds having EDG (endothelial differentiation gene) receptor antagonism which are useful as active components of drugs for preventing and/or treating inflammatory diseases or the like. SOLUTION: The compounds are represented by formula (I) (wherein R1 is hydrogen or an alkyl group; R2 is hydrogen present at any substitutable position on ring C or a substituent such as a hydroxy group, a carboxy group, and a nitro group; R3 is hydrogen present at any substitutable position on ring D or a substitutent such as a hydroxy group and an aralkyloxy group; X is an alkylamino group, an amino group or the like; Y is a carboxy group, a sulfo group or a phosphono group; Z is oxygen, sulfur or the like; a ring represented by A is a 5- or 6-membered saturated or unsaturated hydrocarbon ring; and a ring represented by B is a 4- or 7-membered saturated or unsaturated hydrocarbon ring containing one -C=C- as a partial structure shown in the above formula) and include their salts and their esters.